BioXcel Therapeutics, Inc. (BTAI)
1.74
+0.26
(+17.57%)
USD |
NASDAQ |
Mar 09, 16:00
1.74
0.00 (0.00%)
After-Hours: 16:05
BioXcel Therapeutics SG&A Expense (TTM) : 20.78M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Rigel Pharmaceuticals, Inc. | 85.91M |
| Puma Biotechnology, Inc. | 70.85M |
| Quince Therapeutics, Inc. | 15.70M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |